1.5. Analysis.
Comparison 1: Effect of immunotherapy for surgically treated NSCLC patients: main analyses, Outcome 5: Overall survival rate, 3‐year
Comparison 1: Effect of immunotherapy for surgically treated NSCLC patients: main analyses, Outcome 5: Overall survival rate, 3‐year